drugset / Trial / NCT00199264
Efficacy Vulvovaginitis Candida
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare the therapeutic efficacy of 10 mg, 40 mg, 80 mg, 160 mg and 320 mg of albaconazole, as a single oral dose, in women affected by acute non-complicated vulvovaginitis due to Candida spp.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albaconazole | Small molecule | 10 mg | Oral |
| Subject | Albaconazole | Small molecule | 40 mg | Oral |
| Subject | Albaconazole | Small molecule | 80 mg | Oral |
| Subject | Albaconazole | Small molecule | 160 mg | Oral |
| Subject | Albaconazole | Small molecule | 320 mg | Oral |